1. Home
  2. ACHV vs INVZ Comparison

ACHV vs INVZ Comparison

Compare ACHV & INVZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$4.56

Market Cap

172.0M

Sector

Health Care

ML Signal

HOLD

Logo Innoviz Technologies Ltd. Ordinary shares

INVZ

Innoviz Technologies Ltd. Ordinary shares

HOLD

Current Price

$0.67

Market Cap

144.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACHV
INVZ
Founded
N/A
2016
Country
United States
Israel
Employees
N/A
415
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
172.0M
144.1M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ACHV
INVZ
Price
$4.56
$0.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$14.67
$2.68
AVG Volume (30 Days)
1.6M
2.1M
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$29.61
Revenue Next Year
N/A
$53.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.00
$0.58
52 Week High
$6.03
$2.54

Technical Indicators

Market Signals
Indicator
ACHV
INVZ
Relative Strength Index (RSI) 60.45 47.93
Support Level $4.04 $0.61
Resistance Level $5.13 $0.74
Average True Range (ATR) 0.42 0.05
MACD 0.04 0.01
Stochastic Oscillator 44.16 45.68

Price Performance

Historical Comparison
ACHV
INVZ

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

About INVZ Innoviz Technologies Ltd. Ordinary shares

Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.

Share on Social Networks: